NCT05569213 (DBS MEP) is a clinical trial of motor evoked potentials in MEP Onset Latency, sponsored by University of Manitoba.

Who is sponsoring NCT05569213?

NCT05569213 is sponsored by University of Manitoba.

What drugs are being tested in NCT05569213?

Interventions in NCT05569213: motor evoked potentials.

What condition does NCT05569213 study?

NCT05569213 studies MEP Onset Latency.

Is NCT05569213 still recruiting?

NCT05569213 is currently status unknown. Last updated 6 October 2022.

Last reviewed 2022-10-06 · How we verify

NCT05569213: DBS MEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deep Brain Stimulation (DBS) and Motor Evoked Potentials (MEP)

Status unknown Last updated 6 October 2022

What this trial tests

trial testing motor evoked potentials in MEP Onset Latency in 10 participants. Status unknown.

Timeline

1 October 2022

Primary endpoint
1 October 2023

1 December 2023

Quick facts

Lead sponsor	University of Manitoba
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10
Start date	1 October 2022
Primary completion	1 October 2023
Estimated completion	1 December 2023

Drugs / interventions tested

motor evoked potentials

Conditions studied

MEP Onset Latency — all drugs for MEP Onset Latency →

Sponsor

University of Manitoba

Who can join

Adults 35 to 75, any sex, with MEP Onset Latency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MEP onset latencies from the hand muscle using two different stimulus methods will be compared from each study participant. Conventional MEP data will be collected prior to skin incision. Following the DBS insertion hand muscle evoked responses will be generated via the DBS electrode. A hand held DBS programmer will be connected to the proximal end of the implanted DBS for delivery of electrical stimuli. Stimulus intensity will be adjusted until a hand muscle evoked potential is registered from the same recording electrodes used for the conventional MEP acquisition. A STN-implanted electrode can produce hand muscle responses due to it's close proximity to the motor fibres of the internal capsule. When the conventional and DBS-induced hand muscle responses have been acquired the study data objectives have been met. Data will be analyzed off-line.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Manitoba trials

Trials by the same sponsor.

NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05569213 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
Last refreshed: 6 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05569213.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing